Page last updated: 2024-08-21

6-aminonicotinamide and Neoplasms

6-aminonicotinamide has been researched along with Neoplasms in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (44.44)	18.7374
1990's	1 (11.11)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (33.33)	24.3611
2020's	1 (11.11)	2.80

Authors

Authors	Studies
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L	1
Boussiotis, VA; Cassel, T; Daneshmandi, S; Fan, TW; Higashi, RM; Lin, P; Seth, P; Wulf, GM	1
Bhardwaj, R; Dwarakanath, BS; Sharma, PK; Varshney, R	1
Bhardwaj, R; Jadon, SP; Sharma, PK; Varshney, R	1
DIETRICH, LS; SHAPIRO, DM; SHILS, ME	1
FUGMANN, RA; KLIGERMAN, MM; MARTIN, DS	1
DIETRICH, LS; FRIEDLAND, IM; KAPLAN, LA; MARTIN, DS	1
DEWEY, DL; HAWES, C	1
Carmona, A	1

Reviews

1 review(s) available for 6-aminonicotinamide and Neoplasms

Article	Year
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nature cell biology, 2015, Volume: 17, Issue:11 Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction	2015

Article

Year

6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.

Nature cell biology, 2015, Volume: 17, Issue:11

Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction

2015

Other Studies

8 other study(ies) available for 6-aminonicotinamide and Neoplasms

Article	Year
Blockade of 6-phosphogluconate dehydrogenase generates CD8 Cell reports, 2021, 03-09, Volume: 34, Issue:10 Topics: 6-Aminonicotinamide; Animals; CD8-Positive T-Lymphocytes; Cell Differentiation; Cell Line, Tumor; Granzymes; Humans; Immunotherapy; Listeria monocytogenes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Neoplasms; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Transplantation, Heterologous	2021
Metabolic oxidative stress induced by a combination of 2-DG and 6-AN enhances radiation damage selectively in malignant cells via non-coordinated expression of antioxidant enzymes. Cancer letters, 2010, Sep-28, Volume: 295, Issue:2 Topics: 6-Aminonicotinamide; Antioxidants; Catalase; Cell Line, Tumor; Deoxyglucose; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Humans; NADP; Neoplasms; Oxidative Stress; Radiation Tolerance; Superoxide Dismutase	2010
A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2012, Volume: 33, Issue:4 Topics: 6-Aminonicotinamide; Apoptosis; Blotting, Western; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Checkpoints; Cell Division; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Cyclin A; Cyclin B; Cyclin-Dependent Kinases; Deoxyglucose; Flow Cytometry; G2 Phase; Humans; Neoplasms; Reactive Oxygen Species	2012
Quantitative biochemical differences between tumor and host as a basis for cancer chemotherapy. V. Niacin and 6-aminonicotinamide. Cancer research, 1957, Volume: 17, Issue:6 Topics: 6-Aminonicotinamide; Antineoplastic Agents; Humans; Neoplasms; Niacin; Nicotinic Acids	1957
Radiotherapy and adjuvant combination chemotherapy (6-aminonicotinamide and 6-mercaptopurine). Cancer research, 1958, Volume: 18, Issue:8 Part 1 Topics: 6-Aminonicotinamide; Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Chemotherapy, Adjuvant; Drug Therapy, Combination; Mercaptopurine; Neoplasms; Neoplasms, Experimental; Niacin; Nicotinic Acids; Peptides; X-Rays	1958
Quantitative biochemical differences between tumor and host tissue. VI. 6-Aminonicotinamide antagonism of DPN-dependent enzymatic systems. Cancer research, 1958, Volume: 18, Issue:11 Topics: 6-Aminonicotinamide; Antineoplastic Agents; Coenzymes; NAD; Neoplasms; Niacin; Nicotinic Acids	1958
6-AMINONICOTINAMIDE AND THE RADIOSENSITIVITY OF HUMAN LIVER CELLS IN CULTURE. Nature, 1963, Dec-21, Volume: 200 Topics: 6-Aminonicotinamide; Animals; Carcinoma, Ehrlich Tumor; Chromosomes; Fetus; Liver; Mice; Neoplasms; Neoplasms, Experimental; Niacin; Niacinamide; Radiation Tolerance; Research; Tissue Culture Techniques	1963
[Drugs, inhibitors and other stories. From cancer chemotherapy to nutritional toxicology]. Acta cientifica venezolana, 1999, Volume: 50, Issue:4 Topics: 6-Aminonicotinamide; Animals; Enzyme Inhibitors; Gluconates; Glycolysis; Isothiuronium; Neoplasms; Nutritional Physiological Phenomena; Oryza; Rats; Retrospective Studies; Tannins; Toxicology	1999